www.pharmablog.nl

Weblog met nieuws over de pharmaceutische industrie

Archive for March, 2010

The Associated Press: Under the new health care law, “pharmaceutical lobbyists won new federal policies they coveted and set a trajectory for long-term industry growth.” Ramsey Baghdadi, a Washington health policy analyst, “projects a $30 billion, 10-year net gain for the industry. ‘I don’t see how they could have done much better,’” he said…
Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • GenVec, Inc. (Nasdaq: GNVC) announced that it is discontinuing its Phase 3 clinical trial of TNFerade™ in patients with locally advanced pancreatic cancer based on results of an interim analysis. This interim analysis of overall survival, conducted after the 184th death (two-thirds of total expected events), was designed to determine whether the study should continue…
    Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • Cephalon, Inc. (Nasdaq: CEPH) announced the company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for its supplemental new drug application for NUVIGIL® (armodafinil) Tablets [C-IV] in the treatment of patients with excessive sleepiness associated with jet lag disorder resulting from eastbound travel…
    Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • Trius Therapeutics, Inc. announced results from its Phase 1 clinical trial evaluating the safety, tolerability and pharmacokinetics of the intravenous (IV) dosage form of torezolid phosphate, an IV and orally administered second generation oxazolidinone for the treatment of serious gram positive infections, including methicillin-resistant Staphylococcus aureus (MRSA)…
    Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • Enobia Pharma Inc. unveiled findings from the first hypophosphatasia (HPP) self-reported patient survey intended to evaluate the burden of illness associated with HPP at the 2010 American College of Medical Genetics (ACMG) Annual Clinical Genetics Meeting…
    Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • GlaxoSmithKline (NYSE: GSK) announced that it has re-submitted the supplemental New Drug Application (sNDA) for Avodart® (dutasteride) for prostate cancer risk reduction among men at increased risk of developing the disease to the US Food and Drug Administration (FDA). The re-submission provides an update to the initial application in 2009…
    Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • Virginia Gov. Bob McDonnell traveled to the Center for Innovative Technology and the Northern Virginia Technology Council’s base in Herndon Tuesday to sign several bills passed by Virginia lawmakers as part of the Governor’s “Jobs and Opportunity” legislation package.

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • The Humana Foundation and employees of health insurer Humana Inc. have contributed more than $265,000 for relief efforts in Haiti, following the devastating earthquake on Jan. 12. (HUM)

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • Study: 2 BJC hospitals in top 100

    Two St. Louis-area BJC HealthCare facilities are among Thompson Reuters 100 Top Hospitals, based on a national benchmarks study for 2009. (TRI)

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • CAE Healthcare has acquired part of Immersion Corp.’s medical simulation business unit and licensed its TouchSense Technology, the companies said Tuesday. (CAE) (IMMR)

    Lees meer..

  • 0 Comments
  • Filed under: 3